Background: Acute coronary syndrome (ACS)-induced posttraumatic stress disorder (PTSD) and clinically significant PTSD symptoms (PTSS) are found in 4 and 12% of patients, respectively. We hypothesized that trauma-focused counseling prevents the incidence of ACS-induced PTSS. Methods: Within 48 h of hospital admission, 190 patients with high distress during ACS were randomized to a single-session intervention of either trauma-focused counseling or an active control intervention targeting the general role of stress in patients with heart disease. Blind interviewer-rated PTSS (primary outcome) and additional health outcomes were assessed at 3 months of follow-up. Trial results about prevalence were compared with data from previous studies on the natural incidence of ACS-induced PTSS/PTSD. Results: Intention-to-treat analyses revealed no difference in interviewer-rated PTSS between trauma-focused counseling (mean, 11.33; 95% Cl, 9.23-13.43) and stress counseling (9.88; 7.36-12.40; p = 0.40), depressive symptoms (6.01, 4.98-7.03, vs. 4.71, 3.65-5.77; p = 0.08), global psychological distress (5.15, 4.07-6.23, vs. 3.80, 2.60-5.00; p = 0.11), and the risk for cardiovascular-related hospitalization/all-cause mortality (OR, 0.67; 95% CI, 0.37-1.23). Self-rated PTSS indicated less beneficial effects with trauma-focused (6.54; 4.95-8.14) versus stress counseling (3.74; 2.39-5.08; p = 0.017). The completer analysis (154 cases) confirmed these findings. The prevalence rates of interviewer-rated PTSD (0.5%, 1/190) and self-rated PTSS were in this trial much lower than in meta-analyses and observation studies from the same cardiology department. Conclusions: Benefits were not seen for trauma-focused counseling when compared with an active control intervention. Nonetheless, in distressed ACS patients, individual, single-session, early psychological counseling shows potential as a means to prevent posttraumatic responses, but trauma-focused early treatments should probably be avoided.

Keywords:
Acute coronary care, Behavioral cardiology, Emergency psychiatry, Myocardial infarction, Posttraumatic stress disorder, Prevention, Psychological stress, Trauma stress
1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5. Arlington, American Psychiatric Publishing, 2013.
2.
Whitehead DL, Strike P, Perkins-Porras L, Steptoe A: Frequency of distress and fear of dying during acute coronary syndromes and consequences for adaptation. Am J Cardiol 2005;96:1512−1516.
3.
Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y: Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS One 2012;7: 38915.
4.
Von Känel R, Hari R, Schmid JP, Wiedemar L, Guler E, Barth J, Saner H, Schnyder U, Begré S: Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol 2011;58:61−68.
5.
Wasson LT, Shaffer J, Alcántara C, Schwartz JE, Edmondson D: The association of posttraumatic stress disorder and quality of life during the first year after acute coronary syndrome. Int J Cardiol 2014;176:1042−1043.
6.
Edmondson D, von Känel R: Post-traumatic stress disorder and cardiovascular disease. Lancet Psychiatry 2017;4:320−329.
7.
Rose S, Bisson J, Churchill R, Wessely S: Psychological debriefing for preventing posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2002;2:CD000560.
8.
Bisson JI, Brayne M, Ochberg FM, Everly GS Jr: Early psychosocial intervention following traumatic events. Am J Psychiatry 2007;164:1016−1019.
9.
Witteveen AB, Bisson JI, Ajdukovic D, Arnberg FK, Bergh Johannesson K, Bolding HB, Elklit A, Jehel L, Johansen VA, Lis-Turlejska M, Nordanger DO, Orengo-García F, Polak AR, Punamaki RL, Schnyder U, Wittmann L, Olff M: Post-disaster psychosocial services across Europe: the TENTS project. Soc Sci Med 2012;75:1708−1714.
10.
Bryant RA: Early intervention after trauma; in Schnyder U, Cloitre M (eds): Evidenced Based Treatments for Trauma-Related Psychological Disorders: A Practical Guide for Clinicians. Cham, Springer International Publishing, 2015, pp 125−142.
11.
Roberge MA, Dupuis G, Marchand A: Post-traumatic stress disorder following myocardial infarction: prevalence and risk factors. Can J Cardiol 2010;26:e170−e175.
12.
Guler E, Schmid JP, Wiedemar L, Saner H, Schnyder U, von Känel R: Clinical diagnosis of posttraumatic stress disorder after myocardial infarction. Clin Cardiol 2009;32:125−129.
13.
Wiedemar L, Schmid JP, Müller J, Wittmann L, Schnyder U, Saner H, von Känel R: Prevalence and predictors of posttraumatic stress disorder in patients with acute myocardial infarction. Heart Lung 2008;37:113−121.
14.
Whitehead DL, Perkins-Porras L, Strike PC, Steptoe A: Post-traumatic stress disorder in patients with cardiac disease: predicting vulnerability from emotional responses during admission for acute coronary syndromes. Heart 2006;92:1225−1229.
15.
Meister R, Princip M, Schmid JP, Schnyder U, Barth J, Znoj H, Herbert C, von Känel R: Myocardial Infarction - Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: study protocol for a randomized controlled trial. Trials 2013;14:329.
16.
Herbert C, Wetmore A: Overcoming Traumatic Stress. A Self-Help Guide Using Cognitive Behavioral Techniques. New York, Basic Books, 2008.
17.
Ehlers A, Clark DM, Hackmann A, McManus F, Fennel M, Herbert C, Mayou R: A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry 2003;60:1024− 1032.
18.
Freedland KE, Mohr DC, Davidson KW, Schwartz JE: Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med 2011;73:323−335.
19.
Hari R, Begré S, Schmid JP, Saner H, Gander ML, von Känel R: Change over time in posttraumatic stress caused by myocardial infarction and predicting variables. J Psychosom Res 2010;69:143−150.
20.
Von Känel R: Psychosocial stress and cardiovascular risk: current opinion. Swiss Med Wkly 2012;142:w13502.
21.
Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB: Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006;333:1091.
22.
Beck AT, Steer RA: Manual for the Beck Depression Inventory. San Antonio, Psychological Corporation, 1993.
23.
Barth J, Paul J, Klesse C, Bengel J, Härter M: Die Diskriminationsleistung des Beck- Depressions-Inventars (BDI) hinsichtlich depressiver Störungen bei Patienten mit einer körperlichen Erkrankung. Z Klein Psychol Psychother 2007;36:73-82.
24.
Bryant RA, Moulds ML, Guthrie RM: Acute Stress Disorder Scale: a self-report measure of acute stress disorder. Psychol Assess 2000;12:61-68.
25.
Franklin CL, Sheeran T, Zimmerman M: Screening for trauma histories, posttraumatic stress disorder (PTSD), and subthreshold PTSD in psychiatric outpatients. Psychol Assess 2002;14:567-571.
26.
Schnyder U, Moergeli H: German version of Clinician-Administered PTSD Scale. J Trauma Stress 2002;15:487-492.
27.
Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM: The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995;8:75-90.
28.
Foa EB, Cashman L, Jaycox L, Perry K: Validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychol Assess 1997;9:445-451.
29.
Klaghofer R, Brähler E: Konstruktion und teststatistische Prüfung einer Kurzform der SCL-90-R. Z Klin Psychol Psychiatr Psychother 2001;49:115-124.
30.
Gander ML, von Känel R: Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur J Cardiovasc Prev Rehabil 2006;13:165-172.
31.
Bisson J, Andrew M: Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2007;3:CD003388.
32.
Abbas CC, Schmid JP, Guler E, Wiedemar L, Begré S, Saner H, Schnyder U, von Känel R: Trajectory of posttraumatic stress disorder caused by myocardial infarction: a two-year follow-up study. Int J Psychiatry Med 2009;39:359-376.
33.
Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI: Systematic review and meta-analysis of multiple-session early interventions following traumatic events. Am J Psychiatry 2009;166:293-301.
34.
Shemesh E, Koren-Michowitz M, Yehuda R, Milo-Cotter O, Murdock E, Vered Z, Shneider BL, Gorman JM, Cotter G: Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics 2006;47:231−239.
35.
Weinert C, Meller W: Medical post-traumatic stress disorder: catching up with the cutting edge in stress research. Crit Care 2007;11:118.
36.
Mehnert A, Berg P, Henrich G, Herschbach P: Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology 2009;18:1273-1280.
37.
Edmondson D: An enduring somatic threat model of posttraumatic stress disorder due to acute life-threatening medical events. Soc Personal Psychol Compass 2014;8:118-134.
38.
Meli L, Alcántara C, Sumner JA, Swan B, Chang BP, Edmondson D: Enduring somatic threat perceptions and post-traumatic stress disorder symptoms in survivors of cardiac events. J Health Psychol, Epub ahead of print.
39.
Fava GA, Cosci F, Sonino N: Current psychosomatic practice. Psychother Psychosom 2017; 86:13-30.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.